Literature DB >> 3396471

Preventative antibiotics for penetrating abdominal trauma--single agent or combination therapy?

B A Bivins1, L Crots, V J Sorensen, F N Obeid, H M Horst.   

Abstract

In this open, prospective, comparative study, 75 patients who sustained penetrating abdominal trauma were randomised to receive 1 of 3 antibiotic regimens preoperatively and for 3 to 5 days postoperatively. Group I received cefotaxime 2g 8-hourly, group II received cefoxitin 2g 6-hourly and group III received clindamycin (900 mg 8-hourly) and gentamicin 3 to 5 mg/kg/day in divided doses 8-hourly. The 3 groups were not statistically different in terms of age, sex, severity of injury, number of organs injured, colon injuries, shock, blood transfusions or positive intra-operative cultures. Septic complications occurred in 8% of patients in group I, in 4% of group II patients and in 8% of group III patients. Cefotaxime was the least costly regimen, followed by cefoxitin, then clindamycin and gentamicin. It may be concluded that single agent therapy with a broad spectrum cephalosporin is preferable to combination therapy on the basis of equivalent effectiveness, less toxicity and lower costs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396471     DOI: 10.2165/00003495-198800352-00022

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  15 in total

Review 1.  Principles and practice of antibiotic therapy for post-traumatic abdominal injuries.

Authors:  H Thadepalli
Journal:  Surg Gynecol Obstet       Date:  1979-06

2.  Third-generation cephalosporins for polymicrobial surgical sepsis.

Authors:  H H Stone; P R Strom; T C Fabian; W E Dunlop
Journal:  Arch Surg       Date:  1983-02

3.  The influence of dose frequency and agent toxicity on the cost of parenteral antibiotic therapy.

Authors:  R P Rapp; C L Bannon; B A Bivins
Journal:  Drug Intell Clin Pharm       Date:  1982-12

4.  Risk of infection after penetrating abdominal trauma.

Authors:  R L Nichols; J W Smith; D B Klein; D D Trunkey; R H Cooper; M F Adinolfi; J Mills
Journal:  N Engl J Med       Date:  1984-10-25       Impact factor: 91.245

5.  A prospective comparison of two regimens of prophylactic antibiotics in abdominal trauma: cefoxitin versus triple drug.

Authors:  S R Hofstetter; H L Pachter; A A Bailey; G F Coppa
Journal:  J Trauma       Date:  1984-04

6.  A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis.

Authors:  J J Schentag; P B Wels; D P Reitberg; P Walczak; J H Van Tyle; R J Lascola
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

7.  Bacteriological findings in the first 12 hours following experimental missile trauma.

Authors:  B Dahlgren; R Berlin; A Brandberg; B Rybeck; T Seeman
Journal:  Acta Chir Scand       Date:  1981

8.  The efficacy of cefoxitin vs. clindamycin/gentamicin in surgically treated stab wounds of the bowel.

Authors:  P N Heseltine; T V Berne; A E Yellin; M A Gill; M D Appleman
Journal:  J Trauma       Date:  1986-03

9.  Preoperative antibiotics for abdominal gunshot wounds. A prospective, randomized study.

Authors:  F A Moore; E E Moore; M R Mill
Journal:  Am J Surg       Date:  1983-12       Impact factor: 2.565

Review 10.  'Breakthrough' enterococcal septicemia in surgical patients. 19 cases and a review of the literature.

Authors:  S H Dougherty; A B Flohr; R L Simmons
Journal:  Arch Surg       Date:  1983-02
View more
  2 in total

Review 1.  Methods of minimising the cost of aminoglycoside therapy to hospitals.

Authors:  C A Gentry; K A Rodvold; J S Bertino
Journal:  Pharmacoeconomics       Date:  1993-03       Impact factor: 4.981

2.  Prophylactic antibiotics for penetrating abdominal trauma: duration of use and antibiotic choice.

Authors:  Philip J Herrod; Hannah Boyd-Carson; Brett Doleman; James Blackwell; John P Williams; Ashish Bhalla; Richard L Nelson; Samson Tou; Jon N Lund
Journal:  Cochrane Database Syst Rev       Date:  2019-12-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.